Dear Colleagues
I believe Dr Watine's interpretation is not correct: I cannot find
the conclusion that any of the current hCG kits are suitable for
oncology - perhaps Cathie Sturgeon will give her interpretation.
The most positive step would be for each user to write to their hCG
kit supplier and ask whether their kit is suitable for oncology. I
predict that for most kits the reply would be negative. Roche might
reply in the affirmative, but only for their European kit. In the US,
no commercial kits for hCG have FDA approval for oncology.
Hugh Mitchell
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|